NCT06421285 Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
| NCT ID | NCT06421285 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asan Medical Center |
| Condition | Breast Neoplasms |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-01-10 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-01-10 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Research purpose: Lymphedema is a very common complication in breast cancer patients. However, since there is currently no curable treatment, it is important to prevent and reduce the severity of lymphedema. The purpose of this study is to evaluate whether preoperative exercise is effective in preventing lymphedema after surgery. For secondary outcome, the preventive effects of exercise on other upper extremity dysfunctions (eg. pectoralis tightness, Axillary web syndrome, Adhesive capsulitis), which are common in breast cancer patients, were assessed.
Eligibility Criteria
Inclusion Criteria: * Patients aged 20 or older and younger than 80 who were first diagnosed with breast cancer * Patients scheduled for surgery and starting neoadjuvant chemotherapy before surgery Exclusion Criteria: * Patients with medical contraindications to exercise intervention or pain or musculoskeletal conditions that may limit active exercise intervention
Contact & Investigator
Jaeyong Jeon
PRINCIPAL INVESTIGATOR
Asan Medical Center
Frequently Asked Questions
Who can join the NCT06421285 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 80 Years, studying Breast Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06421285 currently recruiting?
Yes, NCT06421285 is actively recruiting participants. Contact the research team at jyjeon71@gmail.com for enrollment information.
Where is the NCT06421285 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06421285 clinical trial?
NCT06421285 is sponsored by Asan Medical Center. The principal investigator is Jaeyong Jeon at Asan Medical Center. The trial plans to enroll 60 participants.